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From November 6 to 9, 2007, more than 500 scientists from 20 countries and regions gathered in Shanghai,
China, to attend the 2007 Shanghai International Symposium on Stem Cell Research. This dynamic meeting
was jointly organized by the International Society for Stem Cell Research (ISSCR), the Shanghai Institutes for
Biological Sciences, Chinese Academy of Sciences (SIBS/CAS), and other institutes in China. For the first
time, the ISSCR added its name to a conference other than its own annual meeting, embracing this opportu-
nity to learn more about research that is happening in China and providing a platform for local researchers
who do not always have the opportunity to travel internationally to the ISSCR annual meetings. Here we pres-
ent a sampling of the diverse research presented by the local and international participants during the
science-packed 4 day meeting.The Shanghai symposiumwas a concentrated, interactive meet-
ing, providing researchers with many opportunities to discuss
their work and hear that of others. More than 70 investigators
gave oral presentations, and two poster sessions were held
with 102 submitted abstracts. Many investigators focused on
recent, unpublished findings.
Derivation of New Pluripotent Stem Cells, the Germline,
and Embryology
Qi Zhou (CAS, Beijing) shared his experience in somatic cell
nuclear transfer (SCNT) in various animals ranging from mice
and rats to cows and monkeys as part of his studies of reprog-
ramming and the developmental events of early embryos. In
addition, Zhou and collaborators in Guanzhou and Shanghai
have established two parthenogenetic human embryonic stem
cell (ESC) lines (Mai et al., 2007). A further report of a parthenoge-
netic human ESC line wasmade by Ge Lin in Guanxiu Lu’s group
(Central South University, Changsha, China), who derived a line
from an activated oocyte following a standard in vitro fertilization
(IVF) procedure (Lin et al., 2007). In the latter study, it seems the
oocyte was not fertilized but was somehow activated by the IVF
procedure, resulting in one pronucleus in the center of ooplasm
with a second body extrusion. After 5 days of culture, it devel-
oped into the blastocyst stage and, despite poor morphology,
an ESC line was established and propagated. Molecular analy-
ses revealed that the derived human ESC line is parthenogenetic
with a high degree of homozygosity. These reports, together with
two others earlier this year (Kim et al., 2007; Revazova et al.,
2007), suggest that derivation of human parthenogenetic ESC
lines may not be as difficult as previously thought.
George Daley (Harvard Medical School and Children’s Hospi-
tal Boston, Boston) first described efforts in his laboratory to
derive human ESC lines using poor-quality embryos after IVF.34 Cell Stem Cell 2, January 2008 ª2008 ISSCRHe reported that they established 11 human ESC lines from
day 3–5 IVF embryos that would otherwise be discarded without
clinical use (Lerou et al., 2007). Daley also reported their latest
findings to reprogram human somatic cells using a procedure
similar to that first described by Yamanaka and colleagues at
Kyoto University (Kyoto, Japan) (Takahashi and Yamanaka,
2006). Although the four factors described by Yamanaka (Oct4,
Sox2, Klf4, and c-Myc) were sufficient to reprogram human fetal
lung fibroblasts back to an ESC-like state, reprogramming post-
natal human cells occurswithmuch lower efficiency and required
supplemental factors to generate induced pluripotent stem (iPS)
cells in Daley’s laboratory (Park et al., 2007). Together with other
reports published since the meeting (Takahashi et al., 2007; Yu
et al., 2007), this marks the first wave of direct reprogramming
of human somatic cells to iPS cells with few defined factors, sim-
ilar to successful stories with mouse cells published by several
laboratories.KonradHochedlinger (MassachusettsGeneralHos-
pital, Boston) reported his progress in characterizing mouse iPS
cells, including their epigenetic properties, a critical comparison
needed to establish the full picture of similarities and differences
between ES cells and iPS cells. Holm Zaehres (Max Planck Insti-
tute for Molecular Medicine, Mu¨nster, Germany) talked about
GFP reporter systems under the control of anOct4 or Nanog pro-
moter element. These novel systems may aid us in monitoring
more efficiently reprogramming of human somatic cells.
ShengDing (Scripps Institute, La Jolla, CA) introduced achem-
ical screening approach to identify small molecules with applica-
tions in stem cell biology. His group identified a novel molecule
that substitutes for LIF in the propagation of undifferentiated
mouse ESCs. This molecule also appears useful to derive ESC
lines from other species. Ding also reported efforts to substitute
small molecules for transgene expression in the reprogramming of
mouse somatic cells to an ESC-like state. Using reprogramming
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systems, only two of the four transgenes were required to derive
mouse ESC-like cells.
Wenzhi Ji (Kunming Institute of Zoology/CAS, Kunming,
China) focused his talk on the characterization of rabbit ESC
lines. They resemble primate (monkey and human) ESC lines
rather than their mouse counterparts in cell-surface marker
expression and responses to BMP4, activin/nodal/TGFb, and
bFGF. Furthermore, the derived rabbit ESC lines readily differen-
tiate into trophoblast cells spontaneously or upon BMP stimula-
tion, as reported for primate ESCs but in contrast tomouse ESCs
(Xu et al., 2002). Bertrand Pain (Ecole Normale Superieure de
Lyon, Lyon, France) reported the molecular characterization of
chick ESCs, cultured blastodermal cells from which they had
derived the ESCs, and germinal cells. The chick ESCs expressed
at high levels a set of key genes associated with pluripotency,
including cPouf5 (also known as Oct3/4), Nanog, and Gcnf.
Fanyi Zeng (Shanghai Institute of Medical Genetics and
Shanghai Jiaotong University School of Medicine, Shanghai,
China) reported the characterization of global changes in gene
expression and the identification of key molecular processes in
mouse preimplantation stages that accompany and likely un-
derlie the important transitions in early mouse embryos. For ex-
ample, fertilization resulted in changes in the transcript profile in
the one-cell embryo that were far greater than previously recog-
nized, and genome activation during the two-cell stagewas quite
selective rather than global and promiscuous. To investigate
other factors affecting early embryonic development and reprog-
ramming, they used bovine embryos and SCNT to explore the
effects of mitochondrial DNA haplotypes on SCNT embryo
development. They found that themitochondrial structure, quan-
tity, and functions significantly affect the developmental compe-
tence of reconstructed embryos (Jiao et al., 2007). Zichuan Liu of
Nathalie Beaujean’s group (Institut national de la recherche
agronomique [INRA], Jouy en Josas, France) reported on their
analysis of trichostatin (TSA) effects on the reorganization of nu-
clear structure inmouse parthenogenetic embryos. Interestingly,
TSA treatment resulted in extended survival of parthenogenetic
fetuses after embryo transfer.
Karim Nayernia (University of Newcastle upon Tyne, Newcas-
tle upon Tyne, UK) presented a hypothesis in which certain so-
matic cells could be direct descendants of the germ lineages.
He also reported progress on ESC-derived gametogenesis. Lixin
Feng (Shanghai Jiaotong University School of Medicine, Shang-
hai, China) reported his work on improving mouse ESC-derived
gametogenesis by expressing a germline-specific transgene en-
coding Dazl. Both sperm-like and oocyte-like cellular structures
were formed from R1 mouse ESCs (XY karyotype) after Dazl
transduction and in vitro germline differentiation.
Haifan Lin (Yale University, New Haven, CT) reported his prog-
ress in functional studies of the Piwi protein family and Piwi-
interacting RNAs (piRNAs). The RNA-binding proteins, Piwi and
its mammalian homologs Miwi and Miwi-like (or Mili) in mice and
Hiwi in humans, appear to be critical to stem cell self-renewal
in diverse organisms. There are at least 60,000 species of their
target piRNAs, each 26–32 nucleotides in length. As piRNAs
can positively regulate mRNA stability, and possibly translation
and epigenetics, this represents a brand-newmechanism crucial
for regulating stem cell functions (Yin and Lin, 2007).Adult Stem Cells and Their Niches
and Regulation Mechanisms
A major theme of the meeting was the importance of the micro-
environment, or niche, that maintains stem cells throughout
development and adult life. Linheng Li (Stowers Institute for
Medical Resaarch, Kansas City, MO) proposed a new model in
which distinct subpopulations of hematopoietic stem cells
(HSCs) exist in the bonemarrow of adults. These subpopulations
of HSCs can be distinguished according to the levels of
N-cadherin expression. Toshio Suda (Keio University, Tokyo)
summarized themolecular interactions between the osteoblastic
niche and HSCs and then showed that N-cadherin is expressed
in HSCs and is important for their function. Presenting data from
an animal model in which the Hif1a gene was inactivated in
HSCs, Suda also showed that levels of intracellular reactive
oxygen species (ROS) were critical for determining HSC life
span. Hong Qian from Sten Erik Jacobsen’s and Marja Ekblom’s
groups (Lund University, Lund, Sweden) discussed distinct roles
for integrins a6 and a4 in fetal liver hematopoietic stem and pro-
genitor cell homing. She also described a role for thrombopoietin
as a part of the niche, in the regulation of posttransplantation
HSC expansion as well as the maintenance of adult quiescent
HSCs, a critical mechanism to avoid postnatal HSC exhaustion.
This and a similar study from Suda’s group have since been
published (Qian et al., 2007; Yoshihara et al., 2007).
Tao Cheng (University of Pittsburgh, Pittsburgh, and Tianjin
Institute ofHematology, Tianjin, China) reported his long-standing
studies on the roles of cell-cycle regulation and adult HSC self-
renewal. He and others have previously demonstrated that the
cyclin-dependent kinase inhibitors p21, p27, p16, and p18 are in-
volved in adult stem cell regulation. They directly compared roles
of p18 and p21 in regulating murine HSCs using knockout mice
and bone marrow transplantation systems (Yu et al., 2006).
HSCs that lack p18 had a striking advantage over p21 null or
p27 null cells in long-term engraftment experiments. Tariq Enver
(University ofOxford,Oxford) reported that nephroblastomaover-
expressed (Nov or CCN3) is an important regulator of human
HSCs or progenitors. A knockdown diminishes HSC/progenitor
function, while its overexpression enhances stem cell activity.
The niche in the regulation of neural stem cells was also the
subject of research for many scientists at the meeting. Hongjun
Song (JohnsHopkinsUniversity,Baltimore) presentedhis elegant
work on identifying the factors that are involved inmaintaining the
neural stem cell niche within the dentate gyrus of adult mice. He
also presented data on how newly generated neurons integrated
into existing neural networks. Weimin Zhong (Yale University,
NewHaven, CT) used both fly andmousemodels to demonstrate
that the Numb-mediated symmetric cell division is a mechanism
by which neural stem cells choose between self-renewal and dif-
ferentiation during development. Lingsong Li (Peking University
StemCell ResearchCenter, Beijing) reported his recentdiscovery
that thePax6-Sox2-FGFRpathway is required for neural stemcell
proliferation during the development of cerebral cortex.
Ting Xie (Stowers Institute, Kansas City, MO) reported that
Notch signaling is required for germline stem cell (GSC) niche
formation and maintenance in the Drosophila ovary. During early
development, ectopic Notch activation leads to expansion of the
niche size, and its reduction results in the reduced niche size and
the GSC number, while the absence of Notch signaling causesCell Stem Cell 2, January 2008 ª2008 ISSCR 35
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controlled extrinsically and intrinsically, and manipulation of the
niche signal, adhesion, and ROS-induced cellular damage can
modulate the stem cell aging process (Pan et al., 2007).
ES Cells: Self-Renewal and Pluripotency Mechanisms
Ying Jin (SIBS/CAS and Shanghai Jiaotong University School
of Medicine, Shanghai, China) reported her recent work demon-
strating that downregulation of nucleolar protein, LYAR, in
mouse ESCs significantly reduces cell proliferation, anchor-
age-dependent growth, and teratoma formation. She showed
that LYAR forms a protein complex with nucleolin, thus stabiliz-
ing nucleolin by preventing autodegradation. Gen-Sheng Geng
(Xiamen University, Xiamen, China, and Burnham Institute, La
Jolla, CA) discussed roles for Shp2, an intracellular tyrosine
phosphatase with two SH2 domains, in regulation of human
and mouse ESC differentiation. In mouse ESCs, Shp2 modu-
lates LIF and BMP signaling through Erk, Stat3, and the Smads
and in human ESCs modulates the FGF and BMP pathways via
Erk and Smads.
Linzhao Cheng (Johns Hopkins University, Baltimore) focused
his talk on using human ESCs as a research model for studying
human cell biology and diseases. After several years of efforts,
they generated two clonal human ESC lines lacking the ex-
pression of phosphatidylinositol glycan class A (PIG-A), which
is required for the synthesis of a glycosyl phosphatidylinositol
(GPI)-anchored cell-surface molecules and often mutated in
HSCs of patients with PNH (a rare somatic hematological
disease). Lei Xiao (Shanghai Institute of Biochemistry and Cell
Biology, SIBS/CAS, Shanghai, China) extended his previous
studies demonstrating that activin can aid maintenance of human
ESCs (Xiao et al., 2006). He reported that blocking activin/
nodal/TGFb signaling in human ESCs by selective inhibitors
induced the loss of pluripotency, resulting in trophoblast differ-
entiation as when treated by BMP4. Renhe Xu (University of
Connecticut, Farmington, CT) reported that, although both FGF
and activin positively regulate the growth of undifferentiated
human ESCs, the mechanisms of action are different; FGF sig-
naling promotes proliferation, while activin does not stimulate
cell proliferation.
Directed Differentiation of Embryonic Stem Cells
Xin Wang (Shanghai Institute of Biochemistry and Cell Biology,
SIBS/CAS, Shanghai, China) reported work in his lab to generate
functional hepatocytes from mouse ESCs in vitro. Activation of
both Wnt and nodal signaling can result in production of defini-
tive endodermal cells at 80%–90% of the total ESC-derived
cells. Further differentiation protocols and functional assays
are under test.
Huangtian Yang (SIBS/CAS and Shanghai Jiaotong University
School of Medicine, Shanghai, China) investigated the regulation
of calcium signaling during differentiation of ESCs into cardio-
myocytes and neuronal cells. Using mESCs as an in vitro model,
her lab demonstrated that, in the differentiation of ESC-derived
cardiomyocytes, functional RyR2, the type 2 ryanodine receptor,
is essential to the rapid uptake and frequency of calcium tran-
sients that regulate contractions. Neurogenesis induced by
activation of GABAA receptors and L-type calcium channels
depends critically on a functional RyR2.36 Cell Stem Cell 2, January 2008 ª2008 ISSCRRonald Li (University of California, Davis, Davis, CA) reported
efforts in his group to use various cell- and gene-based ap-
proaches to differentiate human ESCs for cardiac tissue regen-
eration. Zack Wang (Maine Medical Center Research Institute,
Scarborough, ME) reported his progress in generating CD34+
vascular progenitor cells fromhumanESCsunder animal-product-
free conditions by adding BMP4, VEGF, and bFGF sequentially.
Hongkui Deng (Peking University, Beijing) reported his recent
studies using human ESCs to generate insulin-producing cells
in vitro by mimicking the pancreatic islet development process.
The differentiated cells morphologically form islet-like clusters
and can express islet-specific markers such as C peptide,
pdx1, insulin, glucagon, and glut2. They can not only secrete
insulin and C peptide in response to glucose stimulation but
also rescue hyperglycemia in STZ-induced diabetic nude mice.
Su-chun Zhang (University of Wisconsin, Madison, WI) pre-
sented his work on directed differentiation of human ESCs to
the neural lineage. In the past several years, Zhang has devel-
oped a chemically defined in vitro system in which human
ESCs can differentiate into the primitive and the definitive neuro-
ectoderm. Based on such a model system, Zhang was able to
further induce definitive neuroectodermal cells into different
types of nerve cells, including the forebrain glutaminergic and
GABAergic neurons, midbrain dopaminergic neurons, spinal
cord cholinergic neurons, and myelinating oligo-dendrocytes.
Wei Cui (Imperial College, London) presented her work on
directed differentiation of human ESCs into first the definitive
endoderm and then hepatocytes. Both Zhang’s and Cui’s work
underscored the potential of a defined in vitro system of human
ESC differentiation to recapitulate the process of normal organ
development of the body for better future applications.
Stem Cell Applications
Various speakers presented their data on extending the stem
cell research into the application arena. Alan Colman (A*STAR In-
stitute of Medical Biology, Singapore) led the way by providing
a review of the challenges facing new stem cell therapies. He
pointed out that, in addition to the necessary technological ad-
vances, safety and regulatory compliance (e.g., GMP produc-
tion) remain a major hurdle. In part addressing the safety issue
of stem cell therapy, Alex Zhang (Xuanwu Hospital, Beijing)
pointed out that studies with nonhuman primates is a necessary
step before new stem cell-based therapies can be used for
human patients. Zhang’s lab has been working on diabetes and
Parkinson’s using monkey models to test the efficacy and safety
of cell therapy and has shown that b cells derived from adult pan-
creatic progenitor cells were able to ameliorate hyperglycemia in
diabetic monkeys for at least 6 months.
Wei Han (Shanghai Jiaotong University, Shanghai, China)
described the use of chemokine CXCL9 (also known as Mig)
as a bone-marrow-protective measure prior to chemotherapy
that otherwise preferentially kills proliferating hematopoietic pro-
genitors cells in addition to the target cancer cells. CXCL9/Mig
acting through its receptor CXCR3 on bone marrow cells inhibits
G1 to S phase transition of these cells, reducing the toxic effects
of chemotherapy agents such as 5-FU both in vivo (mice) and
in vitro. This study suggests that it may be developed as a new
myeloprotective drug in cancer therapy. Xuetao Pei (Beijing Insti-
tute of Transfusion Medicine, Beijing) presented his work on a
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derived from hepatic stem cells. Hung-Fat Tse (University of
Hong Kong, Pokfulam, Hong Kong) reported on their random-
ized, controlled clinical trial using autologous bone marrow cells
in treating severe ischemic heart diseases.
Global Issues/Beyond the Science
To conclude the meeting, speakers looked beyond the immedi-
ate technical challenges of the field. Jeremy Sugarman (Johns
Hopkins University, Baltimore) discussed bioethics issues
related to stem cell research and treatment as both a physician
and a seasoned ethicist. From his position as cochair of the
Johns Hopkins Embryonic Stem Cell Research Oversight Com-
mittee (ESCRO), he introduced current practices of stem cell
research oversight and the human subject protection provided
by the Institutional Review Board (IRB) in U.S. biomedical
research institutes. Among many new issues and challenges
raised by stem cell research and related applications, Sugarman
emphasized the importance of the Hippocratic oath—to help
and do no harm—in the treatment of patients. Supporting what
John Gearhart had discussed in his opening keynote speech,
Sugarman warned of the risks in rushing to claim effective
stem cell therapies as seen in some cell-based interventions
prematurely or inadequately conducted and publicized.
Good communication of research cannot be emphasized
enough both for individual scientific success and in driving the
field forward in a global and collaborative fashion. Deborah
Sweet (Editor, Cell Stem Cell and Developmental Cell,
Cambridge, MA) and Monya Baker (Nature Publishing Group,
San Francisco, CA) shared their expertise with investigators on
how to publish high-profile papers. Douglas Sipp (Riken Center
for Developmental Biology, Kobe, Japan), chair of the ISSCR’s
International Committee, described ISSCR international activities
and membership. He also introduced other international and
regional collaborations such as a CAS-sponsored international
conference in Beijing on April 18, 2008, and the commencement
of the Stem Cell Network for the Asia and Pacific (SNAP).
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